Navigation Links
Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook
Date:11/10/2009

epresents an emerging opportunity for drug delivery technologies. These technologies are first expected to come to market as reformulations of existing macromolecular therapies, such as insulin. This report analyzes the markets for oral, inhalable, injectable, transmucosal, transdermal and niche drug delivery technologies as they apply to both biotech and traditional pharmacological compounds.

Key Features of This Report:

  • A thorough overview of both marketed and emerging drug delivery technologies set to impact the global pharmaceutical market
  • Analysis of the opportunities and threats to the global drug delivery industry
  • Profiles of drug delivery companies along with key financial figures and technology/product portfolios
  • Market analysis and outlook for the leading drug delivery technologies, including oral, injectable, inhalable, transdermal, transmucosal and niche technologies
  • Profiles of key emerging drug delivery technologies and profiles of leading companies, by type of technology

Who Should Buy This Report:

  • Companies interested in understanding the wider opportunities and challenges in the drug delivery industry
  • Pharma/biotech companies wishing to identify potential drug delivery partners
  • Companies with a need for an expansive overview of the drug delivery market and the R&D trends that are driving the industry forward.

Table of Contents

1 Introducing the Field of Drug Delivery

1.1 The Value of Drug Delivery Systems

1.2 Drug Delivery and Product Differentiation

1.3 Drug Delivery and Patent Extension

1.4 The Optimal Time for Reformulation

1.5 Optimizing R&D Returns Through Drug Delivery

1.6 Opportunities and Threats to the Drug Delivery Sector

1.6.1 Opportunities for Growth in the Drug Delivery Sector

1.
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... --  Cypher Genomics, Inc., the genome informatics company, ... as chief technology officer. Ravenel has more than ... a proven track record of designing and architecting solutions ... been recognized as a top designer and architect of ... for delivering innovative products that operate at scale and ...
(Date:10/1/2014)... Oct. 1, 2014 Ardelyx, Inc. ... biopharmaceutical company focused on cardio-renal, gastrointestinal and ... its 371 patient Phase 2b clinical trial ... bowel syndrome (IBS-C).  Results from this study ... in IBS-C symptoms for tenapanor-treated patients compared ...
(Date:9/30/2014)... This report analyzes the worldwide markets for Enteral ... Enteral Feeding Pumps, Nasogastric Tubes, and Others. The ... Japan , Europe , ... and Rest of World. Annual estimates and forecasts are provided ... analysis is provided for these markets. The report ...
Breaking Medicine Technology:Cypher Genomics Appoints J. Patrick Ravenel Chief Technology Officer 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Global Enteral Feeding Devices Industry 2Global Enteral Feeding Devices Industry 3Global Enteral Feeding Devices Industry 4Global Enteral Feeding Devices Industry 5Global Enteral Feeding Devices Industry 6Global Enteral Feeding Devices Industry 7Global Enteral Feeding Devices Industry 8Global Enteral Feeding Devices Industry 9Global Enteral Feeding Devices Industry 10Global Enteral Feeding Devices Industry 11Global Enteral Feeding Devices Industry 12Global Enteral Feeding Devices Industry 13Global Enteral Feeding Devices Industry 14Global Enteral Feeding Devices Industry 15Global Enteral Feeding Devices Industry 16Global Enteral Feeding Devices Industry 17Global Enteral Feeding Devices Industry 18Global Enteral Feeding Devices Industry 19
(Date:10/1/2014)... PA, October 1, 2014 Patients with increased ... have a greatly increased risk of depression. For ... for chronic hepatitis C virus infection causes depression ... fatty acids, more commonly known as fish oil, ... lowering the risk of heart disease and reducing ...
(Date:10/1/2014)... 01, 2014 Marriagelifeinsurance.com has released ... insurance for retired couples. , Senior citizens can ... security for their loved ones. A joint policy is ... persons pass away. , Life insurance can be ... insurance can even be purchased online, as the application ...
(Date:10/1/2014)... 2014 First Warning Systems, a pioneer ... changes throughout the body, announced the company is changing ... the company’s breadth of upcoming product releases. The initial ... technology. , “Our initial focus will be an ‘Internet ... abnormal circadian cellular changes over time,” said Rob Royea, ...
(Date:10/1/2014)... Join the more than 80 golfers who already ... ever charity golf tournament to benefit Project HEAL, a not-for-profit ... cannot afford treatment. The tournament will be held Monday, Oct. ... , The day-long event starts with 10:30 a.m. check-in and ... will begin at 5 p.m. and will include an auction ...
(Date:10/1/2014)... 01, 2014 Innovations announces the upcoming ... broadcast on Monday, October 20, 2014 at 7:30 a.m. ... will go behind the scenes to learn about Break ... will explore the practical help and information Break the ... the warning signs of abuse, how to navigate the ...
Breaking Medicine News(10 mins):Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2
... Resources Allows Pharmaceutical Brand Managers to Build Patient-Flow ... 11 Decision Resources, one of the world,s ... and healthcare issues, finds that use of Novartis, ... Merck,s Cozaar is influenced by physician perception that ...
... revolutionary new line of health and beauty-nutritional supplements, will ... Avenue in New York City. Functionalab, designed to ... a globally recognized developer of science-based and professionally endorsed ... effectiveness. , , Functionalab represents ...
... May 11 Harris announced today that it is ... to prevent the spread of H1N1 and other viruses. ... the hand sanitizing gel at more than 400 new ... Airport."As Chicago,s hometown bank, we applaud our Mayor, the ...
... FARMINGDALE, N.Y., May 11 Misonix, Inc. (Nasdaq: ... technology, which in Europe is used for the ablation of ... financial results for the three and nine months ended March ... Executive Officer, and Richard Zaremba, Senior VP and Chief Financial ...
... registration for one of 2009,s largest and most important scientific ... of the American Chemical Society (ACS) will be held Aug. ... others are expected to attend the meeting, held in the ... than 8,400 reports on new discoveries about chemistry and a ...
... access to stroke specialists, especially in rural or other ... known as a "mini" or "warning" stroke, should be ... according to two separate scientific statements and a policy ... American Heart Association . , Telemedicine Statement Highlights: ...
Cached Medicine News:Health News:More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro 2Health News:More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro 3Health News:Functionalab Launches Exclusively at Henri Bendel Monday, May 11th, 2009 2Health News:Harris Joins City of Chicago in Support of Maintaining Good Health Habits 2Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 2Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 3Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 4Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 5Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 6Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 7Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 8Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 9Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 10Health News:Videoconferencing can increase patient access to stroke specialists 2Health News:Videoconferencing can increase patient access to stroke specialists 3
... GE Healthcare's new Vivid 7 Dimension cardiovascular ... to give clinicians the first fully integrated ... Vivid 7 Dimension, a latest member of ... new tools for detecting and diagnosing heart ...
... The innovative B-Twin Expandable Spinal System ... fusion procedures. The Implant - preloaded on ... the prepared intervertebral space in a reduced ... then EXPANDED up to 15mm (depending on ...
... Rhe Vivid 7 system is GEs premier ... level of image quality to echocardiography, and ... confidence to clinicians.,By listening to customer input, ... the first ergonomically-designed cardiovascular system that delivers ...
... invented the guidewire-mounted pressure sensor and ... Sensor is the only sensor on ... and flow. With significantly improved maneuverability ... your primary guidewire, as well as ...
Medicine Products: